Key test will be to make UK globally competitive in life sciences: ABPI
The Association of the British Pharmaceutical Industry (ABPI) has welcomed the government’s new Industrial Strategy, but said the key test for life sciences will be whether it can return the UK to international competitiveness.
ABPI chief executive Richard Torbett said, “For UK life sciences, a successful strategy means ensuring the UK is not only a cutting-edge place to research and develop the medicine of the future, but also a country which seeks to embrace and use the life-changing innovations we are developing."